Correlación genotipo-fenotipo de un grupo de pacientes con fibrosis quística

Background: Cystic fibrosis (CF) is the most common lethal autosomic disease in Caucasians, with a global incidence of 1:3000 newborns. More than 900 mutations have been described, involving the Cystic Fibrosis Transmembrane Regulator (CFTR). The ∆F508 mutation is present in 60% of alleles...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Navarro M,Héctor, Kolbach R,Marianne, Repetto L,Gabriela, Guiraldes C,Ernesto, Harris D,Paul, Foradori C,Arnaldo, Poggi M,Helena, Sánchez,Ignacio
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2002
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872002000500001
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872002000500001
record_format dspace
spelling oai:scielo:S0034-988720020005000012002-08-22Correlación genotipo-fenotipo de un grupo de pacientes con fibrosis quísticaNavarro M,HéctorKolbach R,MarianneRepetto L,GabrielaGuiraldes C,ErnestoHarris D,PaulForadori C,ArnaldoPoggi M,HelenaSánchez,Ignacio Cystic fibrosis Cystic fibrosis transmembrane conductance regulator Genetics, medical Background: Cystic fibrosis (CF) is the most common lethal autosomic disease in Caucasians, with a global incidence of 1:3000 newborns. More than 900 mutations have been described, involving the Cystic Fibrosis Transmembrane Regulator (CFTR). The ∆F508 mutation is present in 60% of alleles studied worldwide. Aim: To report 25 patients with cystic fibrosis in whom a genetic study was done. Material and methods: Twenty five patients (14 men, aged between 18 months and 25 years) with a diagnosis of cystic fibrosis based on clinical features plus two abnormal sweat tests are reported. The genetic study considered the 20 most common mutations in cystic fibrosis and was done in genomic DNA of peripheral lymphocytes, by polymerase chain reaction. Results: A mutation was found in 75% of analyzed alleles. deltaF508 was present in 50% of cases (deltaF508/deltaF508 in 8 and deltaF508/other in 11). When deltaF508 was present, pancreatic insufficiency was always a feature and nutritional status was worse. Respiratory involvement was variable, both for homozygous and heterozygous cases. Other severe mutations such as W1282X and G542X were related to clinical manifestations similar to those found in deltaF508 mutation. Diagnosis was made before six months of age in 12 patients. The clinical presentation was meconium ileus and there was a family history of the disease in most cases. The majority of cases of early diagnosis presented severe mutations, but milder respiratory symptoms and lesser nutritional compromise at the time of assessment. Conclusions: Most patients studied had a severe cystic fibrosis mutation, which was associated with more severe respiratory, pancreatic and nutritional involvement. The early diagnosis of the disease, which would allow to improve the prognosis and the quality of life, must be emphasized (Rev Méd Chile 2002; 130: 475-81)info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.130 n.5 20022002-05-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872002000500001es10.4067/S0034-98872002000500001
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Cystic fibrosis
Cystic fibrosis transmembrane conductance regulator
Genetics, medical
spellingShingle Cystic fibrosis
Cystic fibrosis transmembrane conductance regulator
Genetics, medical
Navarro M,Héctor
Kolbach R,Marianne
Repetto L,Gabriela
Guiraldes C,Ernesto
Harris D,Paul
Foradori C,Arnaldo
Poggi M,Helena
Sánchez,Ignacio
Correlación genotipo-fenotipo de un grupo de pacientes con fibrosis quística
description Background: Cystic fibrosis (CF) is the most common lethal autosomic disease in Caucasians, with a global incidence of 1:3000 newborns. More than 900 mutations have been described, involving the Cystic Fibrosis Transmembrane Regulator (CFTR). The ∆F508 mutation is present in 60% of alleles studied worldwide. Aim: To report 25 patients with cystic fibrosis in whom a genetic study was done. Material and methods: Twenty five patients (14 men, aged between 18 months and 25 years) with a diagnosis of cystic fibrosis based on clinical features plus two abnormal sweat tests are reported. The genetic study considered the 20 most common mutations in cystic fibrosis and was done in genomic DNA of peripheral lymphocytes, by polymerase chain reaction. Results: A mutation was found in 75% of analyzed alleles. deltaF508 was present in 50% of cases (deltaF508/deltaF508 in 8 and deltaF508/other in 11). When deltaF508 was present, pancreatic insufficiency was always a feature and nutritional status was worse. Respiratory involvement was variable, both for homozygous and heterozygous cases. Other severe mutations such as W1282X and G542X were related to clinical manifestations similar to those found in deltaF508 mutation. Diagnosis was made before six months of age in 12 patients. The clinical presentation was meconium ileus and there was a family history of the disease in most cases. The majority of cases of early diagnosis presented severe mutations, but milder respiratory symptoms and lesser nutritional compromise at the time of assessment. Conclusions: Most patients studied had a severe cystic fibrosis mutation, which was associated with more severe respiratory, pancreatic and nutritional involvement. The early diagnosis of the disease, which would allow to improve the prognosis and the quality of life, must be emphasized (Rev Méd Chile 2002; 130: 475-81)
author Navarro M,Héctor
Kolbach R,Marianne
Repetto L,Gabriela
Guiraldes C,Ernesto
Harris D,Paul
Foradori C,Arnaldo
Poggi M,Helena
Sánchez,Ignacio
author_facet Navarro M,Héctor
Kolbach R,Marianne
Repetto L,Gabriela
Guiraldes C,Ernesto
Harris D,Paul
Foradori C,Arnaldo
Poggi M,Helena
Sánchez,Ignacio
author_sort Navarro M,Héctor
title Correlación genotipo-fenotipo de un grupo de pacientes con fibrosis quística
title_short Correlación genotipo-fenotipo de un grupo de pacientes con fibrosis quística
title_full Correlación genotipo-fenotipo de un grupo de pacientes con fibrosis quística
title_fullStr Correlación genotipo-fenotipo de un grupo de pacientes con fibrosis quística
title_full_unstemmed Correlación genotipo-fenotipo de un grupo de pacientes con fibrosis quística
title_sort correlación genotipo-fenotipo de un grupo de pacientes con fibrosis quística
publisher Sociedad Médica de Santiago
publishDate 2002
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872002000500001
work_keys_str_mv AT navarromhector correlaciongenotipofenotipodeungrupodepacientesconfibrosisquistica
AT kolbachrmarianne correlaciongenotipofenotipodeungrupodepacientesconfibrosisquistica
AT repettolgabriela correlaciongenotipofenotipodeungrupodepacientesconfibrosisquistica
AT guiraldescernesto correlaciongenotipofenotipodeungrupodepacientesconfibrosisquistica
AT harrisdpaul correlaciongenotipofenotipodeungrupodepacientesconfibrosisquistica
AT foradoricarnaldo correlaciongenotipofenotipodeungrupodepacientesconfibrosisquistica
AT poggimhelena correlaciongenotipofenotipodeungrupodepacientesconfibrosisquistica
AT sanchezignacio correlaciongenotipofenotipodeungrupodepacientesconfibrosisquistica
_version_ 1718436028392407040